Already Registered? Log In Now
Not Registered?
Business Email:
Please complete this form to register for the webcast.
Already Registered?
(* indicates required field)
Please complete this form to register for the webcast.
(* indicates required field)
First Name*:
Last Name*:
Job Title*:
Company*:
Business Email*:
Country*:
--
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
checked
I agree to receive direct marketing about IQVIA group services including by email.
checked
I would like to speak with an IQVIA expert.
By registering for this event, you agree to MJH Life Sciences ®
Terms and Conditions
,
Privacy Policy
, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact
info@mjhassoc.com
.
*Denotes required.
Exploring HIV Research in the PrEP Era: Challenges and Opportunities
This event is now available on demand.
Event overview
Join a conversation around the evolving landscape of HIV research amidst the widespread adoption of pre-exposure prophylaxis (PrEP) as the standard of care for HIV prevention. This webinar aims to provide a comprehensive understanding of the unique challenges and opportunities faced by clinical trials evaluating new prevention strategies.
Three key take-aways
Trial Design and Endpoint Selection in the PrEP Era: Navigating Complexities
Participant Recruitment and Ethical Considerations: Balancing Innovation and Standard of Care
Implementation and Adherence Monitoring: Overcoming Obstacles in the PrEP Era
For any technical questions please contact Jordan Ramesh:
jramesh@mjhlifesciences.com
Pragna Patel, MD, MPH, DTM&H
Chief Medical Officer, Coronaviruses and Other Respiratory Viruses Division
National Center for Immunizations and Respiratory Diseases Centers for Disease Control and Prevention
Dr. Pragna Patel
is a physician and epidemiologist with over 25 years of experience in the practice of medicine and public health combined. She is currently the Chief Medical Officer of CDC's Coronavirus and Other Respiratory Viruses Division.
Most recently, she was employed as a Senior Medical and Science Advisor for the Global Health Center, HIV Prevention Branch where she advises on clinical issues and biomedical interventions, such as pre-exposure prophylaxis (PrEP), relevant to adolescent girls and young women and DREAMS. She founded and co-led the PEPFAR interagency PrEP community of practice and is a member of the WHO Global PrEP Coalition. She advised on USAID-funded PrEP projects as a member of the Microbicide Initiative Advisory Board and is a steering committee member of the NIH Adolescent HIV Prevention and Treatment Implementation Science Alliance and the HLB-SIMPLe Alliance.
Since joining the CDC in 2002 until 2013, Dr. Patel worked in the Division of HIV/AIDS Prevention (DHAP) and made numerous notable contributions to DHAP’s mission. She served as a subject matter expert in chronic diseases, especially cancer, among HIV-infected persons, in HIV transmission, and in acute HIV infection. She participated in multiple workgroups and has contributed to seven guideline documents related to HIV prevention, including a new algorithm for HIV testing in the U.S. and PrEP. She also contributed to the creation of the acute HIV infection case definition used for the U.S. National HIV Surveillance System and had been involved in the funding and implementation of 15 studies related to HIV testing and clinical outcomes. She led an HIV cohort study aimed to examine the natural history of HIV/AIDS in the era of effective therapy and was a member of NA-ACCORD.
Richard M. Novak, MD
Head of the Division of Infectious Diseases at UI Health
UI Health
Infectious disease researcher and clinician
Dr. Richard Novak
has cared for HIV patients for more than 30 years and has been leading the Chicago area in COVID-19 vaccine and treatment research.
His research on HIV focuses on prevention vaccines and microbicides targeted at women at high risk for HIV infection and men who have sex with men.
Novak’s work on COVID-19 has included being the UIC principal investigator of multiple clinical trials sponsored by the National Institutes of Health, including the first clinical trial of a COVID-19 vaccine in Chicago.
Stephen Schrantz, MD
Senior Medical Director
IQVIA
Dr. Steven Schrantz
serves as both Senior Medical Director Infectious Diseases & Vaccines and Medical Strategy Lead, Therapeutic Strategy & Science Unit for IQVIA. He has over 15 years of clinical and research experience in both the CRO setting as well as on the faculty at the University of Chicago. He has expertise in Vaccines and Infectious diseases in adults and children: HIV treatment and prevention, Antimicrobials (MDRs), SARS-CoV-2 treatment and prevention. He also serves an infectious disease clinical practice in outpatient clinic in underserved area of Chicago, as well as Medical Director for a program assisting women living with HIV through pregnancy.
FAQs and System Test
Outlook ❯
Google ❯